- serving the communities of Metro Detroit, Michigan, USA

Crime And Police


South Lyon Pharmacy Penalized In Connection To Tainted Drugs

Lansing, MI - Attorney General Bill Schuette and Department of Licensing and Regulatory Affairs Director Steve Arwood announced that Specialty Medicine Compounding Pharmacy, of South Lyon, and its owner Kenny Walkup, will pay $100,000 in state fines and the formal sanctions of license revocation for Walkup and permanent surrender for Specialty Medicine.

These sanctions come as the result of a formal complaint filed by Schuette after the Department of Licensing and Regulatory Affairs received a report of tainted dextrose injections distributed by pharmacy in October 2013.

“Michigan citizens trust pharmacists to follow the laws designed to keep consumers safe, and these sanctions send the message that we’re serious about public safety and welfare,” said Schuette.

"With these sanctions, we are showing zero tolerance for any pharmacist who does not exercise the highest standard of care and regard for the life and safety of our citizens," said Arwood.

The Michigan Board of Pharmacy Disciplinary Subcommittee approved a consent order that calls for the following sanctions:

- Permanent surrender of Specialty Medicine’s pharmacy license, effectively barring the company from ever doing business again in the state of Michigan.

- Three year revocation of owner-pharmacist Kenny Walkup’s individual pharmacist license. Walkup’s license would not be automatically re-instated at the end of the three year period. He would have to file an application for a new license and go before the Board of Pharmacy to prove why he should be issued a new license.

- $100,000 in total fines paid to the state: $50,000 for the pharmacy and $50,000 for the pharmacist.

Pursuant to state law, Schuette’s office filed a Complaint and Order of Summary Suspension on Tuesday, October 29, 2013 with the Department of Licensing and Regulatory Affairs alleging that Specialty Medicine Compounding Pharmacy was acting as a drug manufacturer by distributing large amounts of medication to various hospitals and clinics in Michigan, including Henry Ford Hospital. Veterinarian clinics may have also received the tainted drugs. The pharmacy was only licensed to fill individual prescriptions for Michigan patients. Walkup had applied for a manufacturer’s license on behalf of Specialty Medicine Compounding Pharmacy. The application was pending at the time of the incident, which gave rise to the administrative complaint filed by Schuette.

Once the Order of Summary Suspension was signed by the Bureau of Health Care Services Director, and served, Specialty Medicine Compounding Pharmacy’s license and Walkup’s Pharmacist and Controlled Substances Licenses were immediately suspended pending the outcome of the disciplinary process. The Department of Licensing and Regulatory Affairs confiscated all controlled substances at the facility in South Lyon, and Specialty Medicine Compounding Pharmacy has ceased operations.

Ongoing Investigation

Schuette noted that in addition to the licensing sanctions announced, he is reviewing whether additional legal action is warranted in connection to reports of tainted dextrose injections allegedly manufactured and distributed by Specialty Medicine Compounding Pharmacy. Staff at Henry Ford Hospital in Detroit recognized foreign objects floating in the vials, and following laboratory confirmation of the contaminate, reported the incident to the Food and Drug Administration and sent a copy of the report to the Department of Licensing and Regulatory Affairs’ Bureau of Health Care Services on October 17, 2013

No Reports of Illness

The Food and Drug Administration (FDA) announced a voluntary recall of the affected drugs on October 22, 2013. More information can be found on the FDA website at

Immediately following the report, the Henry Ford Hospital began efforts to contact their patients who may have received the contaminated drug.

To date, there have been no reports of illness related to the drug.